The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isRegistered in Russia as an immunostimulant, with domestic clinical use in infection and post-surgical immune support behind that registration.
- What to watchA flare of joint or skin symptoms.
How Thymogen works
Khavinson immune dipeptide — stimulates T-cell maturation and innate/adaptive immune balance; the short cousin of Thymalin.
Glu-Trp — a dipeptide, and the shortest thing in this catalog. It is the identified active fragment of Thymalin, which is a genuinely rational piece of drug development: isolate what does the work, drop the extract.
- Injectable
On the goal map: Thymic function & adaptive immunity (Immune resilience)
Research on Thymogen5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
Registered in Russia as an immunostimulant, with domestic clinical use in infection and post-surgical immune support behind that registration. Available there in injectable and nasal forms.
The human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
Correlative data
Used as the synthetic, defined-sequence alternative to Thymalin's extract. Long Russian practice record; almost no independent Western use, so there is little to weigh outside the domestic literature.
How the mechanism reads
Glu-Trp — a dipeptide, and the shortest thing in this catalog. It is the identified active fragment of Thymalin, which is a genuinely rational piece of drug development: isolate what does the work, drop the extract.
MechanisticBeing a defined dipeptide instead of a tissue extract is a real advantage — batch identity is verifiable, which is not true of any of the 'natural' bioregulators. The immune mechanism and its autoimmune caution are the same as Thymalin's.
Mechanistic
Sources
- Deigin V. The First Reciprocal Activities of Chiral Peptide Pharmaceuticals: Thymogen and Thymodepressin, as Examples. International Journal of Molecular Sciences 2024 · PMID 38732260
- Chulanova AA. Hepatoprotective Effects of Thymogen Analogues in Hydrazine Hepatopathy in Rats. Bulletin of Experimental Biology and Medicine 2025 · PMID 40442470
- Chulanova AA. Reparative and Antioxidant Effects of New Analogues of Immunomodulator Thymogen in Experimental Model of Liver Damage. Bulletin of Experimental Biology and Medicine 2023 · PMID 37861903
- Deigin VI. Development of Peptide Biopharmaceuticals in Russia. Pharmaceutics 2022 · PMID 35456550
- Linkova N. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. International Journal of Molecular Sciences 2023 · PMID 37686182
- Khavinson VKh, Rybakina EG, Malinin VV, Pivanovich IY, Shanin SN, Korneva EA. Effects of short peptides on thymocyte blast transformation and signal transduction along the sphingomyelin pathway. Bulletin of Experimental Biology and Medicine 2002;133(5):497-499 · PMID 12420072
- Kazakova TB, Barabanova SV, Khavinson VKh, Glushikhina MS, Parkhomenko EP, Malinin VV, Korneva EA. In vitro effect of short peptides on expression of interleukin-2 gene in splenocytes. Bulletin of Experimental Biology and Medicine 2002;133(6):614-616 · PMID 12447482
- Deigin V. Peptide ILE-GLU-TRP (Stemokin) Potential Adjuvant Stimulating a Balanced Immune Response. International Journal of Peptide Research and Therapeutics 2022 · PMID 36313476
- Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences 2022;23(14):7733 · PMID 35887081
Thymogen safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Active autoimmune disease: more T-cell maturation could flare it.
- Anti-rejection drugs after a transplant.
- Pregnancy or breastfeeding: no data for this dipeptide.
- Allergy to peptide products.
- Under 18: pushing T-cell maturation while the immune system is still forming is untested.
What’s expected
- Likely subtle; the Glu-Trp dipeptide is meant to improve T-cell maturation and immune balance.
- Brief tiredness or low-grade temperature.
- Sore spot where it is applied.
Watch for
- A flare of joint or skin symptoms.
- Swollen lymph nodes.
- Fever that persists.
- Rash or breathing trouble.
Labs that tell you it’s working
- Complete Blood Count (CBC) w/ Differential
- hs-CRP (C-Reactive Protein, High Sensitivity)
- TNF-Alpha (Tumor Necrosis Factor)
- Zinc, Plasma
Thymogen is the Glu-Trp dipeptide, the short cousin of Thymalin; immune counts and cytokines are the logical readout.
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Thymogen FAQ4 common questions
- Is Thymogen approved for human use?
- No. Thymogen is a research compound.
- What is Thymogen researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- Complete Blood Count; hs-CRP; TNF-Alpha; Zinc, Plasma: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Thymogen: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



